The present study defined the distribution of alphabeta and gammadelta T-cell subsets, and the expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the intestinal tract of an outbred population of dogs with no evidence of gastrointestinal disease. A panel of monoclonal antibodies reactive with the canine alphabeta and gammadelta T-cell receptors (TCRs) and human MAdCAM-1 was used in a series of immunoperoxidase or immunofluorescence studies. alphabeta T cells were predominant within the villous lamina propria with a significantly decreasing linear trend from upper villus to crypt (P<0.0001). A proportion of intraepithelial lymphocytes (IELs) also expressed the alphabeta T-cell receptor, with significantly greater numbers in villous than in crypt epithelium (P<0.0001). However, there were no significant differences in the numbers of either lamina propria or epithelial alphabeta T cells between different intestinal regions. gammadelta T cells were rare in the lamina propria, but a prominent gammadelta IEL population was present and shown by double-colour immunofluorescence studies to be principally of the CD4(&)minus;CD8alpha(&)minus; phenotype. MAdCAM-1 was expressed by endothelial cells in the mucosa, sub-mucosa and muscularis layers of all levels of the intestinal tract. In the mucosa, significantly more MAdCAM-1 positive endothelium was present in regions of crypt than villous lamina propria (P<0.0001), but there were no significant differences between expression in different intestinal regions. The quantitative and qualitative data will enable comparisons of these parameters to be made with those in dogs suffering from inflammatory bowel diseases.

Download full-text PDF

Source
http://dx.doi.org/10.1053/jcpa.1999.0328DOI Listing

Publication Analysis

Top Keywords

alphabeta gammadelta
12
gammadelta t-cell
12
t-cell receptors
8
expression mucosal
8
mucosal addressin
8
addressin cell
8
cell adhesion
8
adhesion molecule-1
8
distribution lymphocytes
4
lymphocytes expressing
4

Similar Publications

T cells expressing the γδ T-cell receptor (TCR) represent a numerically small proportion of total T cells. Unlike αβ T cells they are activated by non-peptide antigens independently of MHC-presentation. γδ T cells have been recognized as a favorable prognostic marker across different tumor entities.

View Article and Find Full Text PDF

The first evidence that Orthopoxvirus induced the expansion and the recall of effector innate Vδ2T-cells was described in a macaque model. Although, an engagement of αβ T-cells specific response in patients infected with human monkeypox (Mpox) was demonstrated, little is known about the role of γδ T-cells during Mpox infection. IFN-γ-producing γδ T-cells in the resistance to poxviruses may a key role in inducing a protective type 1 memory immunity.

View Article and Find Full Text PDF

Human γδ T cells in the tumor microenvironment: Key insights for advancing cancer immunotherapy.

Mol Cells

January 2025

Laboratory of Host Defenses, Department of Biological Sciences, KAIST, Daejeon 34141, Republic of Korea; KAIST Institute of Health Science and Technology, KAIST, Daejeon 34141, Republic of Korea. Electronic address:

The role of γδ T cells in antitumor responses has gained significant attention due to their unique major histocompatibility complex (MHC)-independent killing mechanisms, which distinguish them from conventional αβ T cells. Notably, γδ tumor-infiltrating lymphocytes (TILs) have been identified as favorable prognostic markers in various cancers. However, γδ TIL subsets, including Vδ1, Vδ2, and Vδ3, exhibit distinct prognostic implications and phenotypes from one another within the tumor microenvironment (TME).

View Article and Find Full Text PDF

Gamma delta T cells in cancer therapy: from tumor recognition to novel treatments.

Front Med (Lausanne)

December 2024

The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang, China.

Traditional immunotherapies mainly focus on αβ T cell-based strategies, which depend on MHC-mediated antigen recognition. However, this approach poses significant challenges in treating recurrent tumors, as immune escape mechanisms are widespread. γδ T cells, with their ability for MHC-independent antigen presentation, offer a promising alternative that could potentially overcome limitations observed in traditional immunotherapies.

View Article and Find Full Text PDF

Structural characterization of two γδ TCR/CD3 complexes.

Nat Commun

January 2025

Regeneron Pharmaceuticals, Inc., Tarrytown, NY, 10591, USA.

The T-cell receptor (TCR)/CD3 complex plays an essential role in the immune response and is a key player in cancer immunotherapies. There are two classes of TCR/CD3 complexes, defined by their TCR chain usage (αβ or γδ). Recently reported structures have revealed the organization of the αβ TCR/CD3 complex, but similar studies regarding the γδ TCR/CD3 complex have lagged behind.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!